Trillium Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.09M Sell
47,445
-436
-0.9% -$36.3K 0.13% 123
2026
Q2
$3.22M Buy
47,881
+11,177
+30% +$745K 0.1% 143
2026
Q1
$2.3M Buy
+36,704
New +$2.56M 0.08% 150

Other funds holding DXCM

Trillium Asset Management's DXCM Position: Q3 2026 in Review

Trillium Asset Management reduced its DexCom (DXCM) stake by 0.91% in Q3 2026, selling an estimated $36.3K and leaving 47,445 shares worth $4.09M. The position accounts for 0.13% of the portfolio, ranked #123.

Trillium Asset Management first reported a position in DXCM in Q1 2026 and has held it in 3 quarters since. 1,050 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Trillium Asset Management held 47,445 shares of DexCom worth $4.09M as of Q3 2026.
  • Trillium Asset Management sold 436 DexCom shares in Q3 2026, an estimated $36.3K.
  • DexCom made up 0.13% of Trillium Asset Management's portfolio in Q3 2026, its #123 holding.
  • Trillium Asset Management first reported a position in DexCom in Q1 2026 and has held it in 3 quarters since.
  • 1,050 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Trillium Asset Management's 13F filing for Q3 2026, filed 9 Nov 2026.